D variants in the population of D‐negative blood donors in the north‐eastern region of Croatia

Adult Male Rh-Hr Blood-Group System Adolescent Genotype Genotyping Techniques Croatia Blood Donors Exons Middle Aged Real-Time Polymerase Chain Reaction 3. Good health 03 medical and health sciences 0302 clinical medicine D antigen ; D variant ; RHD genotyping ; partial D ; weak D Humans Female Polymorphism, Single-Stranded Conformational Aged
DOI: 10.1111/tme.12726 Publication Date: 2020-10-09T09:34:13Z
ABSTRACT
AbstractObjectivesThe aim of this study was to determine RHESUS D GENE (RHD)allelic variants among Croatian D‐negative blood donors and compare our results with respective data from other European countries.BackgroundAltered or reduced D antigen expression can result in D variants, which can be mistyped and can lead to the alloimmunisation of the blood recipient.RHDgenotyping can distinguish D variants: weak D, partial D and DEL, thus preventing alloimmunisation.Material/methodsA total of 6523 samples obtained from D‐negative Croatian donors were screened for the presence ofRHDusing the real‐time polymerase chain reaction (PCR) method. PCR‐SSP was performed for D variant genotyping by using commercial genotyping kits (Inno‐Train, Kronberg, Germany). Genomic DNA sequencing for all 10 exons of theRHDwas performed when the genotyping kits failed to assign a D variant.ResultsRHDmolecular screening revealed 23 (0.35%)RHD‐PCR positive samples, all C/E positive, in decreasing frequency: 11 hybridRHD‐CE (2‐9) D‐CEvariants, 4 weak partial D type 11 and 2 weak D type 2. Six samples remained unresolved and were sequenced. For 12 of 23 samples (excluding large hybrids), an adsorption/elution of anti‐D serum was performed, confirming that all 12 were RhD+. The calculated frequency of clinically significant D alleles in RhD‐negative blood donors was 1:543 (0.18%) or 1:53 (1.89%) in C/E blood donors.ConclusionData on the significant frequency of D variants among serologically D‐negative blood donors in the north‐eastern region of Croatia could help in introducingRHDmolecular screening of blood donors in a routine workflow.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (28)
CITATIONS (3)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....